Global Database of Emerging Companies

A powerful research and due diligence tool for investors, entrepreneurs, and business development executives

The OneMedPlace Global Database is the best first stop to learning about the companies and technologies shaping the future of health and medicine. To gain access to full access to this database register.

Searched:             1 - 30 of 9980 results       Next >


Portland, OR, USA | DesignMedix is a drug development company focused on overcoming drug resistance, one of the major challenges impacting human health and drug development today.

Embera NeuroTherapeutics

Sudbury, MA, USA | Novel treatments for smoking cessation and cocaine dependence

Cancer Genetics

Rutherford,, NJ, USA | DNA-based cancer diagnostics of hematological, urogenital and HPV-associated cancers.

InnerSpace Medical

Tustin, CA, USA | Providing surgeons and nurses with solutions to treat Traumatic Brain Injury

Cervel Neurotech

Redwood City, CA, USA | Medical devices for brain neuro-modulation.

IntelliCyt Corporation

Albuquerque, NM, USA | Develops cell and bead-based screening solutions for use in phenotypic drug discovery, antibody discovery and in vitro toxicity testing.

Insightra Medical, Inc.

Innovative medical devices for hernia and other general surgical therapies

Trinity Vascular Systems

San Diego, United States | Medical devices capable of rejuvenating dead cardiomyocytes.

AMPT Health

Lincoln,, NE, USA | Facilitates and tracks employee engagement success. Performance management.

Admedus Corp.

Minneapolis, MN, USA | A new generation of tissue bio-implants that more easily integrate into recipient tissue, show less capacity for rejection and have the potential to replace many of the products that surgeons currently use.

MedRock, Inc.

Only therapies clinically shown to eradicate CNP infections and eliminate associated calcification and inflammation

Menon Biosensors, Inc.

Bldg 5, Suite 525, CA, USA | Molecular biochemistry company analyzing for rapid detection and diagnosis of biological pathogens.

BEAT BioTherapeutics Corp.

Therapies for heart disease, based on a fundamental discovery in cardiac muscle contraction

GeneCentric Diagnostics

Developing assays for use in clinical laboratories for diagnosis in cancer treatments

IlluminOss Medical, Inc

Minimally invasive bone fixation technology

Diagnostic Photonics, Inc.

Real-time insight into the microscopic structure of tissue, giving clinicians immediate feedback to optimize patient care in a number of clinical scenarios.

Catasys, Inc.

Los Angeles, CA, USA | Addressing substance dependence as a chronic disease, providing longterm care with interventions, coaching and online aid


Delivering patient engagement solutions that improve outcomes and enhance relationships


DermaLOC™ is an easy and painless way to close cuts and wounds and achieve a professional, cosmetic result.

Cellmid Limited

Sydney, Australia | Cellmid Limited (ASX:CDY) is a biotechnology company listed on the Australian Stock Exchange. The company is developing innovative therapies and diagnostic tests for heart attack, inflammatory diseases and cancer. Cellmid holds the largest and most comprehensive portfolio of intellectual property related to midkine, an extensively validated therapeutic and diagnostic target in inflammation, autoimmunity and cancer. Cellmid is actively looking for partners to commercialise these significant midkine intellectual property assets in ischemia, cancer and inflammatory diseases.

DMF Medical

Halifax, Canada | Designing and developing biomedical devices which make the process of delivering anesthesia safer.

Cerora Inc.

Bethlehem, PA, USA | Healthcare IT, device & software platform for brain injury detection and assessment

Cynapsus Therapeutics

Toronto, Canada |


Export, PA, USA | Sleep apnea and noninvasive respiratory therapy


Hayward, CA, USA | DiaCarta is a medical diagnostics company that is dedicated to improving patient care through novel precision molecular diagnostics: CE/IVD marked tests are available for detection of KRAS, NRAS, EGFR, BRAF, PIK3CA, JAK2 and customizing. HPV QuantiVirus® cervical and head-neck cancer tests allow detection of oncogenic E6/E7 mRNAs from 14 high-risk subtypes and genotyping of HPV 16 and 18, in one simple assay.

Anavex Life Sciences Corp.

Califon, NJ 07830, New Jersey, USA | Discovery and development of new drugs for the treatment of neurological diseases and cancer

Opexa Therapeutics

The Woodlands, TX, USA | Develops treatments for autoimmune diseases.

Micro Interventional Devices

Newton, PA, USA | Developing device for soft-tissue wound closure after heart surgery.

Monteris Medical Corporation

Plymouth, MN, USA | Offers a minimally invasive surgical approach for MRI-Guided neurosurgical ablation.

Michelson Diagnostics

Orpington, United Kingdom |

Searched:             1 - 30 of 9980 results       Next >